Literature DB >> 15922715

A human Langerhans cell-like cell line, ELD-1, promotes CD8 T cells to produce IFN-gamma through CD70-dependent alternative pathway.

Sanju Iwamoto1, Makoto Ishida, Satoshi Tamaoki, Tamio Hagiwara, Hirohiko Sueki, Akira Miyazaki.   

Abstract

A novel pathway of CD8+ T-cell activation by a previously established human Langerhans cell (LC)-like cell line, ELD-1 [Dendritic Cells 9 (1999) 41] is reported. ELD-1 cells possess LC-specific and dendritic cell (DC) lineage-specific markers including Birbeck granules. Intriguingly, ELD-1 cells stimulated interferon (IFN)-gamma production by purified allogeneic CD8+ T cells in an IL-2- but not IL-12-dependent manner, but failed to stimulate CD4+ T cells due to their lack of HLA-DR, CD40, CD80, and CD86 expression. Comparing active and inactive subclones of ELD-1 cells revealed that CD70 was a key molecule determining stimulatory ability. This was confirmed by the ability of transfected CD70-encoding cDNA to confer stimulatory capacity on inactive subclones of ELD-1. Therefore, it is concluded that CD70 expressed on ELD-1 cells has a crucial role in stimulating IFN-gamma production by CD8+ T cells through an alternative pathway which does not require CD4+ T-cell help or CD28-B7 interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922715     DOI: 10.1016/j.cellimm.2005.01.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.

Authors:  Helena Soares; HaeNa Waechter; Nicholas Glaichenhaus; Evelyne Mougneau; Hideo Yagita; Olga Mizenina; Diana Dudziak; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Exp Med       Date:  2007-04-16       Impact factor: 14.307

2.  Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis.

Authors:  Yusuke Takei; Chiyuki Ueshima; Tatsuki R Kataoka; Masahiro Hirata; Akihiko Sugimoto; Mariyo Rokutan-Kurata; Koki Moriyoshi; Kazuo Ono; Ichiro Murakami; Sanju Iwamoto; Hironori Haga
Journal:  Oncotarget       Date:  2017-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.